DrugPatentWatch Database Preview
Capsaicin - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for capsaicin and what is the scope of freedom to operate?
Capsaicin
is the generic ingredient in one branded drug marketed by Averitas and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Capsaicin has one hundred and one patent family members in twenty-nine countries.
There are six drug master file entries for capsaicin.
Summary for capsaicin
| International Patents: | 101 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 6 |
| Bulk Api Vendors: | 115 |
| Clinical Trials: | 173 |
| Patent Applications: | 4,042 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for capsaicin |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for capsaicin |
| What excipients (inactive ingredients) are in capsaicin? | capsaicin excipients list |
| DailyMed Link: | capsaicin at DailyMed |
Recent Clinical Trials for capsaicin
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institut Claudius Regaud | Phase 2 |
| Cantonal Hospital of Aarau, Switzerland | Phase 2 |
| University Hospital, Basel, Switzerland | Phase 2 |
Medical Subject Heading (MeSH) Categories for capsaicin
US Patents and Regulatory Information for capsaicin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for capsaicin
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200506462 | Start Trial |
| Hong Kong | 1136957 | Start Trial |
| Spain | 2288222 | Start Trial |
| Japan | 4279254 | Start Trial |
| Portugal | 1613297 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
